| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $49.6M | -20.8% |
| R&D Expense | $77.0M | +13.0% |
| SG&A Expense | $50.0M | -0.9% |
| Operating Income | -$108.9M | -2.4% |
| Pre-tax Income | -$123.5M | +5.9% |
| Income Tax | $0 | — |
| Net Income | -$137.7M | -2.7% |
| EPS (Basic) | -$0.70 | +11.4% |
| EPS (Diluted) | -$0.70 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $43.5M | -42.5% |
| Accounts Receivable | $9.5M | -15.2% |
| Inventory | $2.2M | +23.2% |
| Current Assets | $99.3M | -42.5% |
| Total Assets | $174.7M | -27.7% |
| Current Liabilities | $30.4M | +9.6% |
| Total Liabilities | $161.2M | +26.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$89.1M | +8.5% |
| Capital Expenditures | $5.3M | -37.9% |
| Investing Cash Flow | $28.4M | +149.0% |
| Financing Cash Flow | $30.2M | -79.6% |
| Free Cash Flow | -$94.4M | +10.8% |
| +11.4% |
| Stockholders' Equity |
| $13.4M |
| -88.3% |